Management of thrombosis during pregnancy.
Inbal
Aida
A
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000150:complications; D000991:Antithrombins / Q000172:deficiency; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control / Q000628:therapy*; D011644:Puerperal Disorders / Q000628:therapy; D011655:Pulmonary Embolism / Q000517:prevention & control; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control; D019851:Thrombophilia / Q000150:complications; D013927:Thrombosis / Q000517:prevention & control / Q000628:therapy*; D013997:Time Factors
D000925:Anticoagulants; D000991:Antithrombins; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D001241:Aspirin